Galangin Abrogates Ovalbumin-Induced Airway Inflammation via Negative Regulation of NF-𝜿B

Figure 2

Treatment with galangin decreases the development of AHR in a murine model of asthma. Data are expressed as means ± SEM (𝑛=6 per group). ^#𝑃<0.05 compared with the control group; ^∗𝑃<0.05 compared with the OVA group, ⁺𝑃<0.05 compared with the OVA+GA 15 group.